|
  
- 积分
- 97
- 威望
- 97
- 包包
- 3142
|

本帖最后由 bobo 于 2009-6-28 08:34 编辑
4 u& F# X+ p# N0 U5 o' \ Z# I% `) V& ]7 q0 X9 o ^
表观遗传学与干细胞——2009年亚洲生物高峰论坛录制(音频mp3)
3 N7 D' c4 d: l1 a& i: l4 r7 j* x/ }' b( W" r) c& O2 D
# U" l x9 x9 }! b$ P; Y! |* R* d2 G; \" v8 j& }: r: J
回复为ppt
1 |9 B+ O5 |/ Z3 Z c7 Q摘要:6 e7 f$ M4 S9 m1 P
/ {$ H( i7 ^0 c! K' s/ P' Y" pHongkui Deng+ a6 ~5 {+ C: f) w! t, B! |
% x8 @- A) r; v6 z2 x% D" oLaboratory of Stem Cell and Generative Biology, College of Life Sciences, Peking University, Beijing 100871, China.
3 d0 J) u% r, {8 m0 l$ k: X' n+ @* B+ F' @9 }# O u
Human pluripotent stem cells represent a potentially unlimited source of functional pancreatic endocrine lineage cells. We established a new highly efficient approach to induce human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells to differentiate into mature insulin-producing cells in a chemical-defined culture system. The differentiated cells obtained by this approach comprised nearly 25% insulin-positive cells as assayed by flow cytometry analysis, which released insulin/C-peptide in response to glucose stimuli in a manner comparable to that of adult human islets. Most of these insulin-producing cells co-expressed mature beta cell-specific markers such as NKX6-1 and PDX1, indicating a similar gene expression pattern to adult islet beta cells in vivo. This work provides a new model to study the mechanism of human pancreatic specialization and maturation in vitro, and enhances the possibility of utilizing patient-specific iPS cells for the treatment of diabetes- v: J/ X3 j2 D) b4 a
2 T E* M9 j) t9 L+ b( f- H0 j- o- N
回复为ppt
8 c8 _/ G% T2 X) h- Z* ?: n. |- W+ x4 g; d$ u
2 u6 f4 ^* W' M/ j' q5 u% {2 b
; ]9 ^* Q% H0 t7 k2 |" U
6 O3 w/ A. O8 `% ] |
附件: 你需要登录才可以下载或查看附件。没有帐号?注册
|